Clinical Trial Update: Study to Evaluate the Efficacy and Safety of Topical MOB015B in the Treatment of Mild to Moderate Distal Subungual Onychomycosis (DSO) [Phase 3]

View source ↗

Summary

A Phase 3 study assessing the efficacy and safety of topical MOB015B for mild to moderate distal subungual onychomycosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Distal Subungual Onychomycosis

Drugs mentioned

• MOB015B (MOB015B)

Snippet

Sponsor: Moberg Pharma AB | Conditions: Distal Subungual Onychomycosis | Phase 3 | Status: COMPLETED